Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

Jeffrey S. Parkin

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 15 Dec, 2021
"Remove inverse infobox"
Golden AI profile picture
Golden AI
edited on 15 Dec, 2021
Edits made to:
Infobox (-151 properties)
Infobox
Patent primary examiner of
‌
US Patent 7090851 Long lasting fusion peptide inhibitors of viral infection
‌
US Patent 7094405 Peptides which elicit a high neutralizing antibody titer, cytotoxic T lymphocyte response and T helper cell response in a broad range of MHC type recipients
‌
US Patent 7105169 Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use
‌
US Patent 7118751 DNA vaccines encoding antigen linked to a domain that binds CD40
‌
US Patent 7118859 Methods for inhibiting HIV-1 infection
‌
US Patent 7122188 Antibodies which bind with proteins of human immunodeficiency virus type 1 (HIV-1), and immune complexes comprising proteins of HIV-1
‌
US Patent 7122190 Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids
‌
US Patent 7128915 Membrane virus host range mutations and their uses as vaccine substrates
‌
US Patent 7129324 Secreted and transmembrane polypeptides and nucleic acids encoding the same
‌
US Patent 7138119 Compositions and methods for inhibition of HIV-1 infection
‌
US Patent 7179468 Antigen for developing neutralizing antibodies to human immunodeficiency virus
‌
US Patent 7201903 Method and device for detecting feline immunodeficiency virus
‌
US Patent 7202331 Therapeutic anti-cytomegalovirus compounds
‌
US Patent 7211260 Infectious bursitis vaccine
‌
US Patent 7217418 Multivalent dengue virus vaccine
‌
US Patent 7217506 Mutational profiles in HIV-1 protease correlated with phenotypic protease inhibitor resistance
‌
US Patent 7217812 Extraneous DNA sequence that facilitates hantavirus gene expression
‌
US Patent 7226598 Peptide inhibitors of HIV entry
‌
US Patent 7226602 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
‌
US Patent 7227011 Nucleic acid vaccines for prevention of flavivirus infection
‌
US Patent 7229625 Retrovirus-like particles made non-infectious by a plurality of mutations
‌
US Patent 7232685 Cell lines with latent immunodeficiency virus and methods of use thereof
‌
US Patent 7255862 ALVAC/FIV constructs
‌
US Patent 7255996 Compositions, methods and kits for detecting the nucleic acids of HIV-1 and HIV-2
‌
US Patent 7273614 Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids
‌
US Patent 7276227 Obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity
‌
US Patent 7276242 Vipox vector coding an HIV antigen and a cytokine
‌
US Patent 7276334 Construction and characterization of monoclonal antibodies against western equine encephalitis virus
‌
US Patent 7285272 Method and device for detecting feline immunodeficiency virus
‌
US Patent 7285278 Method and device for detecting feline immunodeficiency virus
‌
US Patent 7285280 Vaccine
‌
US Patent 7291338 Method and device for detecting feline immunodeficiency virus
‌
US Patent 7297476 Method of monitoring HIV assembly and maturation
‌
US Patent 7297784 DNA encoding T-1249 and other viral fusion inhibitor peptides useful for treating aids
‌
US Patent 7304127 Polypeptides that bind HIV gp120 and related nucleic acids, antibodies, compositions, and methods of use
‌
US Patent 7306798 Immunoglobulin IgG3 as a marker for protecting against infectious viral diseases, and the uses of the same
‌
US Patent 7311916 Methods of eliciting broadly neutralizing antibodies targeting HIV-1 gp41
‌
US Patent 7312031 Alpha-complementation viral fusion assay
‌
US Patent 7318927 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
‌
US Patent 7323174 Modulation of immune response and methods based thereon
‌
US Patent 7335468 TSG101-GAG interaction and use thereof
‌
US Patent 7341731 HIV-2 antigen compositions
‌
US Patent 7345153 Compounds capable of inhibiting HIV-1 infection
‌
US Patent 7351412 Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated-virus (LAV) and proteins encoded by said LAV genomic RNA
‌
US Patent 11180491 Method of treating COVID-19 by administering the CCR5/CCL5 (RANTES) interaction inhibitor maraviroc
‌
US Patent 7378490 Cyclic peptides and aids vaccines
‌
US Patent 7378515 Synthetic gagpol genes and their uses
‌
US Patent 7384637 Drug for AIDS treatment
‌
US Patent 7384734 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors
‌
US Patent 7393631 Method for purifying adenoviruses
‌
US Patent 7417136 Nucleic acid
‌
US Patent 7446170 Method for gene transfer into target cells with retrovirus
‌
US Patent 7459269 Detection of bovine viral diarrhea virus in hair samples
‌
US Patent 7470430 Modifications of HIV, ENV, GAG, and POL enhance immunogenicity for genetic immunization
‌
US Patent 7476390 None
‌
US Patent 7479553 Nucleic acids encoding mutant disulfide bond-stabilized human immunodeficiency virus type 1 (HIV-1) gp140 envelope glycoproteins
‌
US Patent 7482016 Immunogenic compositions comprising HIV-1 acetylated Tat polypeptides
‌
US Patent 7485416 Screening methods for the identification of agents that inhibit SIRT1 Tat deacetylase activity
‌
US Patent 7488481 Polypeptides derived from anti-HIV-1 gp120 antibodies that abrogate gp120 binding to CCR5
‌
US Patent 7488484 Nucleic acid expression cassette encoding an HIV polyprotein comprising the ancillary gene products Vif, Vpu, and Nef
‌
US Patent 7488487 Methods of inducing immune responses through the administration of auxtrophic attenuated dal/dat double mutant Listeria strains
‌
US Patent 7488490 Method of inducing an antigen-specific immune response by administering a synergistic combination of adjuvants comprising unmethylated CpG-containing nucleic acids and a non-nucleic acid adjuvant
‌
US Patent 7491400 Pharmaceutical compositions comprising attenuated HIV-1 nef-deficient viral particles
‌
US Patent 7498424 Nucleic acids encoding a novel influenza virus non-structural protein (NS1)-binding host factor designated NS1I-1
‌
US Patent 7501127 Intergenic regions as novel sites for insertion of HIV DNA sequences in the genome of Modified Vaccinia virus Ankara
‌
US Patent 7504204 Detection of transmissible spongiform encephalopathy (TSE) protein employing a highly sensitive Western blot assay and chemiluminescent detection system
‌
US Patent 7507417 Immunogenic compositions comprising human immunodeficiency virus type 2 (HIV-2) glycosylated and unglycosylated envelope proteins and their methods of preparation
‌
US Patent 7510828 Method of decreasing the infectivity of HIV in a biological sample through the administration of S-antithrombin
‌
US Patent 11186626 Broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fusion loop
‌
US Patent 7521177 Flavivirus detection methods employing recombinant antigens comprising a Japanese encephalitis (JEV) signal sequence
‌
US Patent 7528238 Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)
‌
US Patent 7531638 Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)
‌
US Patent 7531639 Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)
‌
US Patent 7531640 Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)
‌
US Patent 7531641 Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26)
‌
US Patent 7531642 Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26).
‌
US Patent 7534442 Immunogenic compositions comprising covalently bound polysaccharides, antigen, and bacterial toxoid
‌
US Patent 7537769 Webbed immunogens comprising recombinant human immunodeficiency virus (HIV) envelope glycoproteins and the M9 scorpion toxin
‌
US Patent 7541036 Human immunodeficiency virus type 1 (HIV-1) matrix (MA or p17) polypeptide capable of inducing anti-p17 antibodies that neutralize the proinflammatory activities of the MA protein
‌
US Patent 7544467 Method for the identification of compounds capable of activating latent human immunodeficiency virus (HIV)
‌
US Patent 7553618 Method for determining human immunodeficiciency virus type 1 (HIV-1) hypersusceptibility to the protease inhibitor amprenavir
‌
US Patent 7553926 Compositions containing anti-HIV peptides and methods for use
‌
US Patent 7556813 Antiviral peptide-polymer conjugate comprising a polymer covalently attached to two or more synthetic HIV gp41 HR1 and/or HR2 peptides
‌
US Patent 7560118 Attenuated dengue virus comprising mutations in the NS3 gene
‌
US Patent 7566451 Human immunodeficiency virus-neutralizing human antibodies with improved breadth and potency
‌
US Patent 7569228 Fusion proteins of non-attenuated HIV regulatory/accessory proteins
‌
US Patent 7579008 Immunization with an attenuated human rotavirus
‌
US Patent 7579143 Method of assessing the effectiveness of a non-nucleoside reverse transcriptase inhibitor (NNRTI) on a human immunodeficiency virus type 1 (HIV-1)-infected patient
‌
US Patent 7582301 Long-lasting antiviral fusion inhibitor peptide conjugates comprising albumin and human immunodeficiency virus (HIV) peptides
‌
US Patent 7585619 Method for detecting human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) activity
‌
US Patent 7588764 Compositions comprising human immunodeficiency virus Tat adsorbed to the surface of anionic nanoparticles
‌
US Patent 7592014 Stabilized viral envelope proteins and uses thereof
‌
US Patent 7595049 IGG1 monoclonal antibody with anti-HIV neutralizing activity
‌
US Patent 7595050 Human IGM monoclonal antibody capable of inducing apoptosis in HIV-infected cells
‌
US Patent 7608271 Modified human immunodeficiency virus anti-fusogenic GP41 peptides comprising a maleimide-containing group
‌
US Patent 7608273 Recombinant lentivirus encoding modified GP 120 signal sequences
‌
US Patent 7608422 Simian immunodeficiency virus (SIV) molecular clone encoding mutant gag gene lacking inhibitory/instability regions
‌
US Patent 7612168 Modified HIV peptides, antigens, compositions, immunoassay kit and a method of detecting antibodies induced by HIV
‌
US Patent 7618642 Expression cassettes encoding modified human immunodeficiency virus type 1 subtype C envelope glycoproteins
‌
US Patent 7622125 Polycistronic HIV vector constructs
‌
US Patent 7625565 Antiviral compositions comprising lysine-rich histone fractions prepared by pepsin treatment of thymic cell nuclei
‌
US Patent 7625566 Anti-idiotypic monoclonal antibody reactive with HIV neutralizing antibody 2F5
‌
US Patent 7626013 HIV-1 DNA fragments that hybridize to genomic HIV-1DNA
‌
US Patent 7632510 Methods of inducing flavivirus immune responses through the administration of recombinant flaviviruses comprising an engineered japanese encephalitis virus signal sequence
‌
US Patent 7642051 Screening methods for the identification of inhibitors of human immunodeficiency virus (HIV) viral protein R (Vpr) binding to the adenine nucleotide translocator (ANT)
‌
US Patent 7658932 Method of making immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) particles devoid of CD55 and CD59 in the viral membrane
‌
US Patent 7662394 Nucleic acids encoding chimeric
‌
US Patent 7666600 Cross-reactive primers for amplifying the nucleic acids of HIV-1 and HIV-2
‌
US Patent 7691390 Viral protein
‌
US Patent 7700116 Method of inducing an immune response in a host by administering immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) particles devoid of CD55 and CD59 in the viral membrane
‌
US Patent 7700273 Peptidomimetics that mimic a conformational-dependent neutralizing epitope of the human immunodeficiency virus (HIV) CCR5 coreceptor
‌
US Patent 7709006 Hepatitis-C virus testing
‌
US Patent 7718180 Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site
‌
US Patent 7727757 Methods of eliciting antiviral immune responses utilizing viral particles comprising photoinactivated reverse transcriptase
‌
US Patent 7731971 Enhanced CTL epitope-containing HIV-1 reverse transcriptase polypeptides
‌
US Patent 7736649 Methods of inhibiting human immunodeficiency virus infection through the administration of synergistic combinations of anti-CCR5 monoclonal antibodies, fusion inhibitors, and CD4-GP120 binding inhibitors
‌
US Patent 7740858 SARS-CoV-specific B-cell epitope and applications thereof
‌
US Patent 7744897 Human immunodeficiency virus gp41 mimetibody polypeptides
‌
US Patent 7745157 Human lymphocyte medium adjuvant
‌
US Patent 7754420 Methods of using cyanovirins to inhibit viral infection
‌
US Patent 7763254 Human immunodeficiency virus integrase-LEDGF p75 isoform protein-protein interactions
‌
US Patent 7763258 Virus-like particles (VLPs) comprising heterologous multiple membrane spanning proteins
‌
US Patent 7771729 Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant administration of DNA and ALVAC expression vectors
‌
US Patent 7771927 Multiple sclerosis-associated retroviral (MSRV) nucleic acids corresponding to the Env region
‌
US Patent 7785598 Alternate reading frame hepatitis C virus peptides and uses thereof
‌
US Patent 7786288 Immunizing compositions encoding an epitope obtained from the HIV-1 capsid protein cyclophilin A binding site
‌
US Patent 7790171 Antiviral peptides obtained from the tryptophan-rich hydrophobic cluster of the HIV-1 reverse transcriptase
‌
US Patent 7790177 Immunizing compositions comprising recombinant attenuated self-replicating viral RNA replicons encoding an epitope obtained from the HIV-1 matrix protein myrstate binding site
‌
US Patent 7790849 Enhancement of retroviral gene transduction employing polypeptides comprising the fibronectin heparin II binding domain
‌
US Patent 7794725 Isolated peptides derived from human immunodeficiency virus types 1 and 2 containing fusion inhibitory domains
‌
US Patent 7803524 Antigenic HIV gp41 chimeric polypeptides comprising the MVP5180/91 epitope SKGKLIS
‌
US Patent 7811573 Compositions of antigens bound to HIV-1 Tat, fragments or derivatives thereof
‌
US Patent 7811577 Covalently stabilized chimeric coiled-coil HIV gp41 N-peptides with improved antiviral activity
‌
US Patent 7811578 Soluble chimeric peptide inhibitors of HIV entry comprising an IZ trimeric coiled-coil peptide and HIV gp41 N-helix coiled-coil peptide
‌
US Patent 7811580 Chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics that are capable of inducing neutralizing antibody responses against cryptic Env epitopes
‌
US Patent 7858298 Methods of inhibiting human immunodeficiency virus type 1 (HIV-1) infection through the administration of CCR5 chemokine receptor antagonists
‌
US Patent 7888003 Methods for the detection of HIV-1 antibodies employing polypeptides obtained from gag P6 protein
‌
US Patent 7892562 Methods of inducing TH-1 immune responses to HIV-1 by administering UV/psoralen-treated desialated inactiviated HIV-1 virions deficient in CD55 and CD59
‌
US Patent 7897332 Methods for the detection of HIV-1 or -2 antigens employing monoclonal antibodies that recognize a shared HIV-1/-2 epitope in the capsid p24/p26 proteins
‌
US Patent 7901685 Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion
‌
US Patent 7910716 Nucleic acids encoding modified South African HIV-1 subtype C gag proteins
‌
US Patent 7917303 Method for identifying combinations of motifs that do not mutate simultaneously in a set of viral polypeptide sequences comprising a putative drug binding site
‌
US Patent 7919100 Soluble and stabilized trimeric form of gp41 polypeptides
‌
US Patent 7919101 Highly potent synergistic combinations of human immunodeficiency virus (HIV) fusion inhibitors
‌
US Patent 7935797 CCR5 chemokine receptor-specific monoclonal antibodies capable of inhibiting HIV-1 cell fusion
‌
US Patent 7939083 Soluble, stabilized, proteolytically cleaved, trimeric HIV-1 gp140 proteins comprising modifications in the N-terminus of the gp41 ectodomain
‌
US Patent 7943146 Immunizing compositions comprising HIV-1 proviral constructs with an inactive p6 gag TSG101 UEV binding domain capable of producing budding-defective viral particles that remain tethered to the cell surface
‌
US Patent 7947286 Drosophila cell lines producing recombinant secretable filovirus surface glycoproteins lacking the membrane spanning domain
‌
US Patent 7947807 Method for obtaining G protein-coupled receptor (GPCR) diffraction-quality crystals employing a monoclonal antibody that binds to the third intracellular loop (IL3)
‌
US Patent 7951377 Mosaic clade M human immunodeficiency virus type 1 (HIV-1) envelope immunogens
‌
US Patent 7988974 Antifusogenic proteins comprising human immunodeficiency virus type 1 (HIV-1) gp41 DP-178 polypeptide variants and a macromolecular carrier
Edits on 8 Dec, 2021
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7951377 Mosaic clade M human immunodeficiency virus type 1 (HIV-1) envelope immunogens
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7919100 Soluble and stabilized trimeric form of gp41 polypeptides
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7910716 Nucleic acids encoding modified South African HIV-1 subtype C gag proteins
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7901685 Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Edits on 6 Dec, 2021
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021

Find more people like Jeffrey S. Parkin

Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo